FLINT — Diplomat, the nation’s largest independent specialty pharmacy, says it has been chosen the exclusive distributor for Synribo for self-administration at home.
Synribo is prescription medicine used to treat adult patients with chronic or accelerated phase chronic myeloid leukemia who are no longer responding to, or who could not tolerate, two or more other treatments called tyrosine kinase inhibitors.
Previously, it was necessary for adults living with chronic or accelerated phase CML who were prescribed Synribo to travel to a doctor’s office twice a day to receive their therapy. The administration schedule was burdensome for some patients and their caregivers and created a potential barrier to treatment. According to the American Cancer Society, a little more than 10 percent of leukemia diagnoses each year are CML, which affects the blood and bone marrow.
Synribo is manufactured by Teva Pharmaceutical Industries Ltd.
Headquartered in Flint, Diplomat focuses on medication management programs for people with complex chronic diseases, including cancer, immune disorders, hepatitis, multiple sclerosis, HIV, and other serious or long-term conditions.
More at http://diplomat.is.